eCite Digital Repository

Inhaled anticholinergic medications: their role in COPD and adverse cardiovascular events

Citation

Bereznicki, L and Bereznicki, BJ, Inhaled anticholinergic medications: their role in COPD and adverse cardiovascular events, Australian Pharmacist, 29, (8) pp. 690-694. ISSN 0728-4632 (2010) [Professional, Non Refereed Article]


Preview
PDF
Restricted - Request a copy
238Kb
  

Copyright Statement

Copyright 2010 Pharmaceutical Society of Australia

Official URL: http://www.psa.org.au/

Abstract

Chronic obstructive pulmonary disease (COPD) is a major cause of disability, hospital admission and premature death in Australia. More than half a million Australians are estimated to have COPD, and the prevalence is likely to escalate as the population ages

Item Details

Item Type:Professional, Non Refereed Article
Keywords:anticholinergic medications, COPD, effectiveness, adverse effects, heterogeneous disease, lung injury
Research Division:Medical and Health Sciences
Research Group:Pharmacology and Pharmaceutical Sciences
Research Field:Pharmaceutical Sciences
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Respiratory System and Diseases (incl. Asthma)
Author:Bereznicki, L (Professor Luke Bereznicki)
Author:Bereznicki, BJ (Dr Bonnie Bereznicki)
ID Code:64523
Year Published:2010
Deposited By:Pharmacy
Deposited On:2010-08-11
Last Modified:2015-09-07
Downloads:2 View Download Statistics

Repository Staff Only: item control page